We’ll see you all tomorrow starting at 5:00pm in Chicago at AAFP FMX 2023! Make sure to stop by the Tempus booth (#3619) to see/hear how Tempus n/P is delivering on the promise of personalized medicine with The Tempus Platform. Our DATA and EVIDENCE first approach for mental health means that you ALWAYS have access to the latest FDA, CPIC, and expert guidelines to incorporate into your clinical practice, without bias, and promotes standardization. Stop by and see how Tempus n/P is creating a new paradigm for personalized mental health care. Fact: Tempus n/P is building the world’s largest dataset of matched clinical and molecular psychiatric patient records Fact: This is data-driven precision medicine Fact: This IS the future of healthcare Fact: This IS Tempus!!! See you all there!!!
The Hill’s Post
More Relevant Posts
-
Join us Feb. 27 for a webinar featuring a dynamic discussion with experts from AMCP's Market Insights Roundtable on the Impact of Mental Health in Patients Living with Rare Disease. Gain valuable insights as Michael Kobernick, MD, MS-PopH, Senior Medical Director of Blue Cross of MI and Maureen Lyon, PhD, MA, Clinical Health Psychologist at the Center for Translational Research Children's Research Institute provide a comprehensive overview of how #mentalhealth care is currently delivered in the U.S. and identify the gaps that may exist. https://bit.ly/3UOgJtk #managedcare #pharmacy
To view or add a comment, sign in
-
-
Do you know the differences between delirium, depression, and anxiety? Join Dan Marrow, Enclara's Senior Clinical Manager, for an educational session next week at the CAHSAH Annual Conference & Expo to discuss more. #hospice #PalliativeCare
To view or add a comment, sign in
-
-
Executive Assistant and Office Manager - EMEA | Forensic & Litigation | Financial Crime Consulting and Cybersecurity
Psychedelic Frontiers: Diverse Perspectives on a Mental Health Revolution is a series in which FTI Consulting Strategic Communications healthcare public affairs experts explore different perceptions of psychedelic medicine across various stakeholder groups. In Part 2, my colleagues examine the perspectives and contributions by the scientific community to psychedelic research, and share insights on how to effectively navigate the regulatory landscape, engage with stakeholders to gain wider acceptance of these treatments. Learn more: https://lnkd.in/dcNqKxr2 Key contacts: Julie Carney, Michael Adeyanju, Ethan Lutz, and Annika Chauhan #PsychedelicMedicine #PsychedelicResearch #Healthcare #LifeSciences
To view or add a comment, sign in
-
-
Deputy Dean (People, Culture, Inclusion)| Professor in Health Equity| Various Board Roles| Kathak Dancer
Starting the week with a highlight from the last- absolutely loved seeing Kidney Research UK's workshop coming together with the aim of reviewing health inequalities 5 years on. Months of planning, and more to come, facilitating a wide range of stakeholders, change agents, and broader partners in having this important space to reflect, rethink, re-challenge. I always value being part of a research field where patients and their families are so generous with their time, and where you are never short of clinicians who may have no time but make time to enable research for patient and public benefit. When I started my research career, I wouldn’t have thought I’d be part of chairing a workshop like this, with a kidney research team pursuing a range of themes all related to narrowing health gaps. From the intersection of severe mental illness in kidney patients (Lauren Fitzgerald); developing a dialysis related distress tool (Emma Caton); to mitigating specific barriers to kidney research in those experiencing the clustering of disadvantage (Dr Emily Beadle). The best but most uncomfortable part of the day was the patient panel. I’m sure I didn’t always have the right words to express how such varied narratives hit me emotionally and professionally, but definitely a reminder of what we still need to recognise and remove as barriers to living well with kidney disease, or indeed doing more to prevent it where possible. Bigger, bolder, and sustainable change. Meaningful conversations, prioritised action, and a great venue with Conference Aston! #kidneyhealth #kidneydisease #healthinequalities #healthequity #patientcare #coproduction #psychology #qualityoflife #healthpromotion #healtheducation #publichealth #researchimpact #researcher With Prof Fergus Caskey; Dr Gavin Dryer; Dr Bnar Talabani; Prof Liz Lightstone; Kidney Research UK team; Fez Awan; Cllr Hilaria Asumu JP amongst several equally important contributors!
To view or add a comment, sign in
-
I Help Slow GPs Boost Income, Find Purpose, and Lead In Healthcare | NHS GP & TEAM CBT Therapist | Founder of the Slow GP Movement | Principle Physician at WellFounded
Connection is a cure. To ourselves, other people and to nature. What a start to a Friday Morning to speak with 2 powerhouse doctors in the field of community and clinician wellbeing. Dr Emma Presern is a trailblazing GP with her Rebellious health program, midway through the first cohort but with an extremely bright future to help a nation of burnt out medics connect with themselves and each other. Dr Linda Mizun is a social genius A&E doctor who connects streets, neighbourhoods and whole communities in Sheffield and further afield around the topic of holistic, evidence based health. Love powers both of these fantastic women to build better systems and societies to maximise health in patients and clinicians. Today we scheduled a 10 minute catch up about our upcoming “Connect” webinar for Rebellious Health in July. It turned into a recorded 60 minute lively discussion about the immense power for community, emotional authenticity and lifestyle medicine to empower people. We talked about the “5 Secrets of Effective Communication Framework” from TEAM CBT creator, David Burns and how I use it to build trust in GP and cognitive therapy consultations. The bottom line to connection is this. Seek first to understand before being understood. If you are confused about why someone is thinking, feeling or acting in certain ways you haven’t asked the right questions or connected with them fully. It doesn’t have time take hours to connect. It can take as little as 60 empathic seconds. We will share our recording soon so watch this space. 😊
To view or add a comment, sign in
-
-
PracticeWise Co-founder and President, Dr. Bruce Chorpita, will be taking the virtual stage representing UCLA Psychology Department for an exclusive webinar with live Q&A! 📅 Date: April 2, 2024 🕠 Time: 5:30 PM PT Topic: "Leveraging Psychological Science to Make a Difference in the Clinic and Community: Interventions with Breast Cancer Survivors and Community Mental Health for Young People" Join Dr. Bruce Chorpita as he shares insights on how their work can create meaningful impacts in the world. This is an opportunity to hear directly from him about the importance of psychological science and its role in transforming communities. Additionally, emphasizing the need for industrial partnerships to scale science for real-world impact. This indeed promises to be an illuminating conversation alongside Julie Bower, Professor in the Department of Psychology, with introductory remarks and a moderated Q&A by Department Chair Annette Stanton. Registration is FREE, and no UCLA affiliation is necessary. Spread the word and mark your calendars. We would love to have the PracticeWise community join. Register via UCLA zoom link: https://lnkd.in/g8MKVbqp. UCLA #Psychology #Mentalhealth #
To view or add a comment, sign in
-
#Accountability, opportunities for early involvement, and thoughtfulness are paramount in patient engagement in research. My colleagues and I just published a paper describing how we engaged patient partners in helping develop a grant for a self-compassion intervention and a protocol for how we will engage patient partners once the project receives further funding. We also report on how engagement shaped the directions of our grant. This is a great read for anyone planning their own engagement protocol or interested in learning more about the benefits of patient engagement in #grantwriting. #ppi #patientexperience #patientengagement #researchprotocol
Excited to announce the publication of a co-authored article on engaging patient and community partners in the optimization of a self-compassion and physical activity behaviour change intervention. This article describes our initial work with patient and community partners, and outlines plans for possible future activities. https://lnkd.in/gTiyBXuR
Engaging patient and community stakeholders in the optimization of the Compassionate And Loving Mindset towards heart health risk (CALM Hearts) physical activity intervention: a description of initial work and protocol for future engagement activities - Research Involvement and Engagement
researchinvolvement.biomedcentral.com
To view or add a comment, sign in
-
"What we really need to do as scientists is push that needle forward in working to reduce [disparities.]" In just a short amount of time chatting with Dr. Mary Ackenbom, I learned so much about #urogynecology, pelvic floor disorders, and the health disparities related to them. Listen in for a bite-sized discussion on what Dr. Ackenbom found when she examined disparities in #PFD care, how her research at Magee-Womens Research Institute & Foundation informs her approach to evidence-based medicine, and what inspires her work as a surgeon-scientist. #womeninmedicine #healthcaredisparities #pelvicfloordisorders
🎙️ Just in! Dr. Mary Ackenbom, Magee-Womens investigator, discusses her work on health care disparities, including a recent systematic literature review on pelvic floor disorders. Some takeaways: 💜 Most work focuses on detecting and understanding disparities, but we need to focus on reducing disparities. 💜 Community partnership, research, and awareness is key to bridge the gap. Read more: https://lnkd.in/eUcJjdYk
Q&A with Dr. Ackenbom
To view or add a comment, sign in
-
Psychedelic Frontiers: Diverse Perspectives on a Mental Health Revolution is a series in which FTI Consulting Strategic Communications healthcare public affairs experts explore different perceptions of psychedelic medicine across various stakeholder groups. In Part 2, my colleagues examine the perspectives and contributions by the scientific community to psychedelic research, and share insights on how to effectively navigate the regulatory landscape, engage with stakeholders to gain wider acceptance of these treatments. Learn more: https://lnkd.in/e5i8CCWe Key contacts: Julie Carney, Michael Adeyanju, Ethan Lutz, and Annika Chauhan #PsychedelicMedicine #PsychedelicResearch #Healthcare #LifeSciences
To view or add a comment, sign in
-